Should You Buy The New York Times Company Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, The New York Times Company (NYT) ranks in the top tier of our coverage universe with a Quality of Company score of 9.4/10. Trading at a market price of $71.71, this high-quality profile requires careful comparison against our 13 intrinsic value models.
The short answer: 0 of 11 CirclFi valuation models project upside for The New York Times Company (NYT) at $71.71 — the model consensus leans bearish, with a Quality Score of 9.4/10 and Value-Trap risk of 17/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for The New York Times Company (NYT) in 2026?
What Is the Bull Case vs the Bear Case for The New York Times Company (NYT)?
| Bull case | Bear case — $19.17 target (-73.3%) |
|---|---|
| No active model projects meaningful upside for NYT at $71.71. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. | According to the CirclFi Deep Alpha Valuation Engine, the Earnings Power Value (EPV) model sees the stock as overvalued with a fair value of $19.17 (-73.3%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +65.7% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. | |
| Industry headwind: technology transition capex represents a meaningful risk for The New York Times Company and its Publishing peers. |
How Does NYT Compare to Its Publishing Peers?
Valuation data pages: WLY · WLYB · SCHL · EDUC · PSO · TDAY · LEE · TNMG
Which Other Stocks Score Like NYT on Quality?
Closest companies to NYT’s Quality of Company score of 9.4/10, across all industries.
- ACFN — Acorn Energy, Inc. (QOC 9.4) · analysis
- RMD — ResMed Inc. (QOC 9.4) · analysis
- BLBD — Blue Bird Corporation (QOC 9.4) · analysis
- ONTO — Onto Innovation Inc. (QOC 9.4) · analysis
- ISRG — Intuitive Surgical, Inc. (QOC 9.4) · analysis
- EME — EMCOR Group, Inc. (QOC 9.4) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
So Is The New York Times Company (NYT) Worth Buying in 2026?
Our valuation engine sends a clear cautionary signal on The New York Times Company at $71.71. 11/11 models flag overvaluation, median fair value sits at $41.57 (-42.0%), and the risk-reward profile appears unfavorable. Quality at 9.4/10 is the one bright spot, but premium quality at the wrong price can still destroy returns. This is a stock where patience — or avoidance — may be the optimal strategy.
These are quantitative model outputs, not investment recommendations. The New York Times Company's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About NYT Stock?
Should I buy NYT stock right now?
Based on CirclFi's multi-model analysis, 0 of 11 models see upside for NYT at $71.71. No active models currently project upside, suggesting the market price may already reflect or exceed fair value. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in The New York Times Company?
Key risks include: wide model disagreement (246% spread), signaling high uncertainty; general market and sector-specific risks affecting Publishing companies. Always diversify and consult a financial advisor.
How does NYT compare to its competitors?
Among Publishing peers, NYT holds a Quality Score of 9.4/10. Comparable companies include WLY (QOC 7.9), WLYB (QOC 7.9), SCHL (QOC 7.8). The relative ranking helps investors identify whether NYT offers better fundamental quality than alternatives in the same sector.
Is NYT a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. NYT's Quality Score of 9.4/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy NYT at?
CirclFi does not provide target buy prices or price alerts. However, our 11 active models produce fair value estimates ranging from $19.17 to $66.31. At $71.71, the stock trades above all model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for NYT.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad